Barclay A. Phillips, SVP & Chief Financial Officer at G1 Therapeutics, Inc. (GTHX), sold 5,000 shares at $39.92 ($200K) on 2018-11-15, disclosed to the SEC on 2018-11-16.
Open-market sale of $200k GTHX by SVP & Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NVAX | BUY | 2017-02-02 | $2K | — | Filing → |
| NVAX | BUY | 2016-08-02 | $2K | — | Filing → |
| NVAX | BUY | 2016-02-01 | $2K | — | Filing → |